Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.
JAKKS Pacific, Inc. (NASDAQ: JAKK) shares declined 0.63 percent to close at $4.72 a share Wednesday. The stock traded between $4.71 and $4.99 on volume of 663,444 shares traded. Analysts at Needham have recently upgraded the company’s rating to "hold" from "underperform". Shares of JAKKS Pacific have fallen approximately 62.0 percent year-to-date.
Find out more about JAKKS Pacific including full access to the free equity report at:
www.RDInvesting.com/JAKK
Roundy's Inc. (NYSE: RNDY) shares declined 1.33 percent to close at $8.91 a share Wednesday. The stock traded between $8.90 and $9.25 on volume of 337,111 shares traded. Analysts at Deutsche Bank have recently initiated coverage on the company with a "hold" rating and a price target of $8.50. Shares of Roundy's have gained approximately 100.0 percent year-to-date.
Find out more about Roundy's including full access to the free equity report at:
www.RDInvesting.com/RNDY
United Natural Foods, Inc. (NASDAQ: UNFI) shares declined 0.91 percent to close at $66.76 a share Wednesday. The stock traded between $66.75 and $67.41 on volume of 241,178 shares traded. Analysts at Deutsche Bank have recently initiated coverage on the company with a "hold" rating and a price target of $65.00. Shares of United Natural Foods have gained approximately 25.0 percent year-to-date.
Find out more about United Natural Foods including full access to the free equity report at:
www.RDInvesting.com/UNFI
Vitamin Shoppe Inc. (NYSE: VSI) shares declined 0.71 percent to close at $42.09 a share Wednesday. The stock traded between $41.89 and $42.58 on volume of 340,131 shares traded. Analysts at Deutsche Bank have recently initiated coverage on the company with a "buy" rating and a price target of $52.00. Shares of Vitamin Shoppe have gained approximately 56.0 percent year-to-date.
Find out more about Vitamin Shoppe including full access to the free equity report at:
www.RDInvesting.com/VSI
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]